Headache

Article	Citations
Issue Information	442
Virtual issue: Kids (with headache disorders) are not just little adults (with headache disorders)	75
Issue Information	71
Longitudinal assessment of comorbidities and co‐occurring conditions in adolescents with migraine: A secondary analysis of the National Longitudinal Study of Adolescent to Adult Health (Add Health)	67
RETRACTION: Effectiveness of anti‐CGRP monoclonal antibodies for persistent headaches in patients with idiopathic intracranial hypertension	62
Issue Information	58
	53
Pilot study evaluating treatment with sumatriptan for moderate to severe post‐traumatic headache: A phase 2 open‐label study	53
Not their fault: Mental health characteristics of parents with migraine and the migraine status of their children	51
Plain Language Summary Publication: Hyperactivity of the medial thalamus in patients with photophobia‐associated migraine	47
Headache activity associated with the 2024 North American eclipse	46
Developing multivariable models for predicting headache improvement in patients with acute post‐traumatic headache attributed to mild traumatic brain injury: A preliminary study	46
The Chronic Headache Self‐Efficacy Scale: Development and assessment of measurement properties	45
	45
Prevalence and burden of migraine in the United States: A systematic review	45
Early effect of onabotulinumtoxinA on EEG‐based functional connectivity in patients with chronic migraine: A pilot study	42
Circadian functional changes of pain‐processing brainstem nuclei and implications for cluster headache: A 7 Tesla imaging study	40
Thank you to Dr. Dana Turner	40
Differences in circulating alpha‐calcitonin gene–related peptide levels in inflammatory bowel disease and its relation to migraine comorbidity: A cross‐sectional study	35
Heavy metal and trace element alterations in patients during a migraine attack	33
	31
Lifetime history of an anxiety or depression disorder and adherence to medications used for the acute treatment of migraine	30
Trainee highlights	29
Issue Information	28
Author Index	27

Reversible cerebral vasoconstriction syndrome after levonorgestrel‐releasing intrauterine device placement—Case report	27
Trainee highlights	26
Predictors of migraine interictal burden: The hidden role of subjective memory complaints	26
	26
Artificial intelligence terminology, methodology, and critical appraisal: A primer for headache clinicians and researchers	24
Issue Information	24
Persistence, effectiveness, and tolerability of anti‐calcitonin gene–related peptide monoclonal antibodies in patients with chronic migraine	24
Headache diagnosis and treatment: A pilot knowledge and needs assessment among physical therapists	24
Post‐traumatic headache: An unmet medical need	23
A randomized, open‐label, 5‐period crossover study evaluating the pharmacokinetics and safety of a single dose of intranasal dihydroergotamine (DHE) powder (STS101), intramuscular DHE mesylate, and li	23
Healthcare resource use and costs associated with the misdiagnosis of migraine	23
Safety, tolerability, and effectiveness of repetitive intravenous dihydroergotamine for refractory chronic migraine with cardiovascular risk factors: A retrospective study	23
Visual temporal discrimination is impaired in patients with migraine without aura	22
Intranasal treatment of cluster headache	21
Refractory glossopharyngeal neuralgia successfully treated with onabotulinumtoxinA: A case report	21
Issue Information	21
Continuous updating of individual headache forecasting models using Bayesian methods	21
Popping the balloon: Abrupt onset of a spinal CSF leak and spontaneous intracranial hypotension in idiopathic intracranial hypertension, a case report	20
Migraine and peripheral pain models show differential alterations in neuronal complexity	20
Could osmophobia be a clinical diagnostic marker for migraine?	19
Functional magnetic resonance imaging of headache: Issues, best‐practices, and new directions, a narrative review	19
Migraine screening in English and Spanish	19
Improvements in quality of life and work productivity with up to 6 months of fremanezumab treatment in patients with episodic and chronic migraine and documented inadequate response to 2 to 4 classes	19
Eptinezumab improved patient‐reported outcomes in patients with migraine and medication‐overuse headache: Subgroup analysis of the randomized PROMISE‐2 trial	19
Developing an artificial intelligence–based diagnostic model of headaches from a dataset of clinic patients' records	19
Migraine, idiopathic intracranial hypertension, and calcitonin gene‐related peptide antibodies	18
Current practice for primary headache disorders and perspectives on peripheral nerve blocks among emergency physicians in Canada: A national survey	18
Narrative review of migraine management in patients with renal or hepatic disease	18
A retrospective analysis of the use of candesartan for migraine prevention in adolescents	18
Clinical pattern and response to treatment of primary stabbing headache: Retrospective case series study from a Portuguese tertiary hospital	17
A retrospective cohort study of clinical factors, visit patterns, and demographic factors associated with use of remote communications in patients with headache	17
Issue Information	17
Cerebrovascular reactivity to hypercapnia in patients with migraine: A dual‐echo arterial spin labeling MRI study	17
Drug‐resistant epicrania fugax: Responding to onabotulinumtoxinA	17
Reliability, validity, and responsiveness of the Arabic version of HIT‐6 questionnaire in patients with migraine indicated for preventive therapy: A multi‐center study	17
Comparison of migraine with left‐ versus right‐sided headache: A cross‐sectional study	17
Idiopathic intracranial hypertension presenting with migraine phenotype is associated with unfavorable headache outcomes	16
Nonspecific oral medications versus anti–calcitonin gene‐related peptide monoclonal antibodies for migraine: A systematic review and meta‐analysis of randomized controlled trials	16
The value of the patient perspective in understanding the full burden of migraine	16
Did she have an epidural? The long‐term consequences of postdural puncture headache and the role of unintended dural puncture	16
Effects of caffeine on intracranial pressure and pain perception in freely moving rats	16
Migraine and large artery atherosclerosis in young adults with ischemic stroke	15
Exploratory investigation of a patient‐informed low‐dose psilocybin pulse regimen in the suppression of cluster headache: Results from a randomized, double‐blind, placebo‐controlled trial	15
Sensory hypersensitivities are associated with post‐traumatic headache‐related disability	15
Do behavioral treatments work for migraine prevention?	15
Familial hemiplegic migraine in pediatric patients: A genetic, clinical, and follow‐up study	15
Computed tomography‐guided radiofrequency ablation of cervical intervertebral discs for the treatment of refractory cervicogenic headache: A retrospective chart review	15
Visual inspection versus spectrophotometry for xanthochromia detection in patients with sudden onset severe headache—A diagnostic accuracy study	15
Assessing the influence of migraine on ischemic penumbra and on the prognosis of ischemic stroke: A prospective cohort study	15
Dyspareunia and pelvic pain in women with chronic migraine: A retrospective, observational analysis	14

Vitamin D concentrations in patients with cluster headache: A matched case–control study	14
	14
Localization in headache medicine: A systematic approach to diagnosis	14
Patient headache questionnaires can improve headache diagnosis and treatment in children	14
The 2023 Scottsdale Headache Symposium	14
Low serum 25‐hydroxyvitamin D levels in migraine are not related to headache frequency: A case‐control study in patients with high‐frequency/chronic migraine	14
Ahead of the pain: Where we stand after a decade of growth in United Council for Neurologic Subspecialties‐certified headache subspecialists	13
Characteristics associated with response to subcutaneously administered anti‐CGRP monoclonal antibody medications in a real‐world community cohort of persons living with migraine: A retrospective clin	13
Beyond myths: Transformative insights into spinal cerebrospinal fluid leaks and their role in persistent headache syndromes	13
Effect of caffeine and caffeine cessation on cerebrovascular reactivity in patients with migraine	13
Treatment of multiple sclerosis–related trigeminal neuralgia with onabotulinumtoxinA	13
Treatment of chronic migraine with medication overuse: A perspective	13
Migraine treatment with external concurrent occipital and trigeminal neurostimulation—A randomized controlled trial	12
Understanding the gaps in headache and migraine treatment with psychological and behavioral interventions: A narrative review	12
Eptinezumab for adolescents with chronic refractory headache: A retrospective chart review	12
Hemicrania continua secondary to pituitary macroadenoma responsive to nerve blocks: A case report	12
Celebrating Headache's 2023 graduating class of Assistant Editors	12
The importance of patient and family perspectives of clinical decisions in pediatric headache	12
Characteristics and natural disease history of persistent idiopathic facial pain, trigeminal neuralgia, and neuropathic facial pain	12
Neuralgia in the occipital region associated with ipsilateral trigeminal herpes zoster: Three case reports	12
Telephone follow‐up on treatment and patient satisfaction at a Danish tertiary headache center: A prospective study	12
Combination CGRP monoclonal antibody and onabotulinumtoxinA treatment for preventive treatment in chronic migraine	12
Predictive models for determining treatment response to nonprescription acute medications in migraine: Results from the American Migraine Prevalence and Prevention Study	12
Factors to predict recurrence after epidural blood patch in patients with spontaneous intracranial hypotension	12
Issue Information	12
Migraine in women	12
The headache research priorities: Research goals from the American Headache Society and an international multistakeholder expert group	12
Off‐label use of lacosamide, an alternative for the treatment of neuropathic pain	11
Aura is a symptom of a migraine attack, not its cause	11
Beyond pain control: Outcome and treatment preferences in pediatric migraine	11
The effectiveness of parenteral agents to mitigate relapses after severe acute migraine headache presentations: A systematic review and network analysis	11
Transient side shift of cluster headache attacks after unilateral greater occipital nerve injection	11
Migraine treatment in pregnancy: A survey of comfort and treatment practices of women's healthcare providers	11
Issue Information	11
The 2024 Scottsdale Headache Symposium: A banner year	11
Symptomatic visual snow in acute ischemic stroke: A case series	11
Characteristics of acute ischemic stroke and unusual aura in patients with migraine with aura	11
Basic Science Prize Award 2023	11
Narrative review of peripheral nerve blocks for the management of headache	11
Assessing attack‐related fear in headache disorders—Structure and psychometric properties of the Fear of Attacks in Migraine Inventory	10
Normal glymphatic system function in patients with new daily persistent headache using diffusion tensor image analysis along the perivascular space	10
Normal glymphatic system function in patients with migraine: A pilot study	10
Genetically proxied liability to migraine and risk of intracranial aneurysm and subarachnoid hemorrhage	10
Randomized controlled pilot trial of prazosin for prophylaxis of posttraumatic headaches in active‐duty service members and veterans	10
Erratum	10
A post hoc analysis of migraine‐associated symptoms from the phase 3 randomized, double‐blind, sham‐controlled Trial of External trigeminal nerve stimulation for the Acute treatment of Migraine (	10
A critical appraisal of the International Classification of Headache Disorders migraine diagnostic criteria based on a retrospective multicenter cross‐sectional headache registry study in youth	10
Erratum	10
A narrative review of the importance of pharmacokinetics and drug–drug interactions of preventive therapies in migraine management	9
Phase Ib, open‐label, fixed‐sequence, drug–drug interaction, safety, and tolerability study between atogepant and ubrogepant in participants with a history of migraine	9
Toward a better understanding of persistent headache after mild COVID‐19: Three migraine‐like yet distinct scenarios	9
Use of combined hormonal contraception and stroke: A case‐control study of the impact of migraine type and estrogen dose on ischemic stroke risk	9
Blood pressure elevation in erenumab‐treated patients with migraine: A retrospective real‐world experience	9
Treatment of hemiplegic migraine with anti‐calcitonin gene‐related peptide monoclonal antibodies: A case series in a tertiary‐care headache center	9
Headache response after CT‐guided fibrin glue occlusion of CSF‐venous fistulas	9
Long‐term (48 weeks) effectiveness, safety, and tolerability of erenumab in the prevention of high‐frequency episodic and chronic migraine in a real world: Results of the EARLY 2 study	9
Comparative bioavailability of single‐dose zavegepant during and between migraine attacks: A phase 1, randomized, open‐label, fixed‐sequence, two‐period study	9
Characteristics of men and women with medically diagnosed cluster headache in a national integrated healthcare system: A Veterans Health Administration cohort study	9
The effectiveness of parenteral agents for pain reduction in patients with migraine presenting to emergency settings: A systematic review and network analysis	9
Facial variant of epicrania fugax secondary to a cerebellopontine angle meningioma	9
Mapping the migraine: Intracranial recording of cortical spreading depression in migraine with aura	8
Role of memantine in the prophylactic treatment of episodic migraine: A systematic review	8
Association of periodontal disease with migraine: A large‐scale community‐based cross‐sectional study	8
Anxiety, depression, and headache‐related disability in a large pediatric clinic–based sample	8
Physical activity pattern and migraine according to aura symptoms in the Brazilian Longitudinal Study of Adult Health (ELSA‐Brasil) cohort: A cross‐sectional study	8
	8
The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice	8
Impact of the COVID‐19 pandemic on people living with migraine: Results of the MiCOAS qualitative study	8
The impacts of migraine on functioning: Results from two qualitative studies of people living with migraine	8
Association between secondhand smoke exposure and severe headaches or migraine in never‐smoking adults	8
Migraine and spontaneous coronary artery dissection: A retrospective case–control study	8
Real‐world approaches to outpatient treatment of status migrainosus: A survey study	8
Efficacy and safety of galcanezumab as a treatment of refractory episodic and chronic cluster headache: Case series and narrative review	8
Issue Information	7
	7
Efficacy of an educational website on headaches in schoolchildren: A cluster‐randomized controlled trial	7
Effects of fremanezumab on migraine‐associated symptoms and medication use in Japanese and Korean patients with episodic migraine: Exploratory endpoint analysis of a multicenter, randomized, double‐bl	7
	7
Author Index	7
To test or not to test? Do red flags play any role?	7

Headache: Reflections on 2021 and looking forward to 2022	7
Effect of erenumab versus other migraine preventive medications on cardiovascular and cerebrovascular outcomes: A United States claims database‐based observational cohort study	7
Regulation of headache response and transcriptomic network by the trigeminal ganglion clock	7
Neuromodulation for primary headache disorders: Advantages and challenges	7
The 15‐day threshold in the definition of chronic migraine is reasonable and sufficient—Five reasons for not changing the ICHD‐3 definition	7
Trainee highlights	7
Diagnosing new daily persistent headache in children and adolescents: A survey of clinicians	7
Prevalence of primary stabbing headache: A meta‐analysis	7
Effect of prednisolone for the treatment of medication‐overuse headache: A 3‐month result from a multicenter REgistry for Load and management of mEdicAtion overuSE headache (RELEASE) study	7
Aryl hydrocarbon receptors improve migraine‐like pain behaviors in rats through the regulation of regulatory T cell/T‐helper 17 cell‐related homeostasis	7
Intranasal treatment of cluster headache: A response	6
Improved quality of life with fremanezumab in Japanese and Korean patients with episodic and chronic migraine: Results of two multicenter, randomized, double‐blind, placebo‐controlled, parallel‐group	6
Does “wearing off” of efficacy occur in galcanezumab‐treated patients at the end of the monthly treatment cycle? Post hoc analyses of four phase III randomized trials	6
The teaching of headache medicine in France: A questionnaire‐based study	6
Erratum	6
Issue Information	6
Headache rounds: Postural headache in a patient with squamous cell carcinoma	6
The effect of the COVID‐19 pandemic on headache‐related disability among young adults with migraine	6
Insight of a headache medicine provider in Indian Health Service: A personal and professional observation	6
Issue Information	6
Gene polymorphism association studies in cluster headache: A field synopsis and systematic meta‐analyses	6
Barriers to care in episodic and chronic migraine: Results from the Chronic Migraine Epidemiology and Outcomes Study	6
Author Response to Comment on “Plasma calcitonin gene‐related peptide and nerve growth factor as headache and pain biomarkers in recently deployed soldiers with and without a recent concussion”	6
Indomethacin‐responsive idiopathic red ear syndrome: A pediatric case	6
Headache fellowship match shareholder insights	6
	6
Grand rounds education in neurology, with a focus on headache medicine	6
Secondary cluster headache due to a contralateral demyelinating periaqueductal gray matter lesion	6
Neuropathic changes in corneal nerve endings—A potential objective biomarker for migraine frequency and response to treatment	6
Low pulse pressure and high serum complement C1q are risk factors for hemodialysis headache: A case–control study	6
Indomethacin‐responsive headaches—A narrative review	6
Shaping a new era of medicine at the American Headache Society Annual Scientific Meeting	6
Reduction in retinal microvascular perfusion during migraine attacks	6
Comparative prevalence and characteristics of fabricated citations in large language models in headache medicine	5
Is prednisone still a reasonable option in the treatment of withdrawal headache in patients with chronic migraine and medication overuse headache in the age of CGRP antibodies? A narrative	5
Depression and anxiety in women with idiopathic intracranial hypertension compared to migraine: A matched controlled cohort study	5
Fremanezumab in individuals with chronic migraine who had inadequate response to onabotulinumtoxinA and topiramate or valproic acid	5
Sex and gender: Opportunities to expand research and understanding within headache medicine	5
Hemicrania continua in a family: A report of two cases	5
Radiological features of patients with headache as a presenting symptom of neurosarcoidosis	5
Erratum	5
	5
Memantine for migraine—Big promise but little evidence	5
Altered resting‐state effective connectivity of trigeminal vascular system in migraine without aura: A spectral dynamic causal modeling study	5
Ultrasound‐guided stellate ganglion block for the treatment of migraine in elderly patients: A retrospective and observational study	5
Headache basic science prize	5
Bone site fracture pain after subcutaneous sumatriptan injection: A report of two cases	5
Hyperactivity of the medial thalamus in patients with photophobia‐associated migraine	5
Systematic reviews can guide clinical practice and new research on primary headaches in pregnancy: An editorial on the 2022 American Headache Society Members' Choice Award paper	5
Impact of unilateral trigeminal neuralgia on bilateral ocular surface alterations	5
Correction to “A causative role for remote dural puncture and resultant arachnoid bleb in new daily persistent headache: A case report”	5
Trainee highlights	5
Comparing treatments in the emergency department: What works for migraine?	5
CCH attack frequency reduction after psilocybin correlates with hypothalamic functional connectivity	5
Headache characteristics to screen for cervicocerebral artery dissection in patients with acute onset unusual headache	5
Adaptation of the management of chronic migraine patients with medication overuse to the suspension of treatment protocols during the COVID‐19 pandemic: Lessons from a tertiary headache center in Mila	5
Developing and delivering a migraine disparities and diagnosis undergraduate medical educational program to underrepresented in medicine medical student members of the Student National Medical Associa	5
The use of erenumab for migraine prophylaxis during pregnancy: A case report and narrative review	5
Headache and psychological variables as predictors of disability in individuals with primary headache disorders	5
Correction to “Regional cerebral perfusion during the premonitory phase of triggered migraine: A double‐blind randomized placebo‐controlled functional imaging study using pseudo‐continuous arterial sp	5
Visual aura without headache as a pre‐cluster symptom in episodic cluster headache: A report of two cases	5
Common challenges in the development of prediction models	5